CAR-T cell therapy: a potential new strategy against prostate cancer

Prostate cancer (PCa) is one of the main causes of cancer-related death in men. In the present immunotherapy era, several immunotherapeutic agents have been evaluated in PCa with poor results, possibly due to its low mutational burden. The recent development of chimeric antigen receptor (CAR)-T cell...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunother Cancer
Hlavní autoři: Schepisi, Giuseppe, Cursano, Maria Concetta, Casadei, Chiara, Menna, Cecilia, Altavilla, Amelia, Lolli, Cristian, Cerchione, Claudio, Paganelli, Giovanni, Santini, Daniele, Tonini, Giuseppe, Martinelli, Giovanni, De Giorgi, Ugo
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6794851/
https://ncbi.nlm.nih.gov/pubmed/31619289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0741-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky